Study Stopped
The onset of COVID-19 shut down San Francisco in March 2020, resulting in immediate suspension of group prenatal care at our clinic sites. This continued suspension prevented the conduct of study activities, which resulted in study termination.
CenteringPregnancy Oral Health Promotion
CPOP
2 other identifiers
interventional
N/A
0 countries
N/A
Brief Summary
A five-year, Phase III, multi-site, cluster randomized controlled clinical trial will evaluate the efficacy of the CenteringPregnancy (CP) Oral Health Promotion (CPOP) intervention. Intervention and control groups will be drawn from 6 CP sites. Prenatal care facilitators will conduct the intervention in group prenatal care sessions. With an average of 4 CP facilitators per site (24 facilitators), conducting 2-3 CP groups each (48-72 CP groups with 8 mother/child dyads per group), the total study population will be approximately 384 dyads. CP facilitators will be randomly assigned to either the: 1) intervention arm and deliver the CPOP intervention; or 2) control arm and deliver the usual CP curriculum. The CPOP intervention consists of two 15-minute modules: 1) maternal oral health (OH) and 2) infant OH. The data collection will continue through 12 months postpartum. For the maternal OH module, pre- and post-intervention dental exams of gingival OH and Plaque Levels, and knowledge, attitudes and behavior (KAB) questionnaires during the prenatal period will be used to assess maternal OH outcomes. For the infant OH module, pre and post-module KAB questionnaires will be completed during the prenatal period. Infant OH risk status - the presence of caries-causing bacteria (mutans streptococci and Lactobacilli) in saliva of both mother and infant will be assessed when the infant is 12 months of age to determine differences in study arms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2020
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2019
CompletedFirst Posted
Study publicly available on registry
June 28, 2019
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2022
CompletedJanuary 23, 2023
January 1, 2023
1.9 years
June 4, 2019
January 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in percent of periodontal probing sites that bleed upon probing
Based on clinical dental exams conducted before the maternal oral health module and approximately 12 weeks following the maternal module, comparisons between the Intervention and Control groups will be conducted to determine differences in change in the percent of periodontal probing sites that bleed upon probing.
12 weeks follow-up
Change in percent of periodontal probing sites that probe at ≥4mm depth
Based on clinical dental exams conducted before the maternal oral health module and approximately 12 weeks following the maternal module, comparisons between the Intervention and Control groups will be conducted to determine differences in change in the percent of periodontal probing sites that probe at ≥4mm depth.
12 weeks follow-up
Change in plaque levels at 24 sites
Based on clinical dental exams conducted before the maternal oral health module and approximately 12 weeks following the maternal module, comparisons between the Intervention and Control groups will be conducted to determine differences in change in plaque levels at 24 sites (4 sites on 6 teeth) using the Plaque Index. Each site is scored from 0-3 (0=no plaque; 3=heavy plaque), yielding a score between 0 and 72.
12 weeks follow-up
Incidence of salivary Mutans Streptococci in infants at 12 months of age
Based on results of assays of infant saliva specimens collected at 12 months of age, comparisons between infants whose mothers were in the Intervention versus the Control groups will be conducted to determine differences in the incidence of Mutans Streptococci.
1-year follow-up postpartum
Secondary Outcomes (12)
Change in maternal oral health knowledge
12 week follow-up
Change in maternal oral health attitude
12 week follow-up
Change in maternal oral health behavior
12 week follow-up
Change in maternal knowledge regarding infant oral health
2 week follow-up
Change in maternal attitude regarding infant oral health
2 week follow-up
- +7 more secondary outcomes
Study Arms (2)
Intervention Arm
EXPERIMENTALCPOP Intervention (see below).
Control Arm
NO INTERVENTIONUsual care.
Interventions
The intervention consists of two 15-minute interactive modules (maternal and infant OH), integrated into 2 group prenatal care sessions. Led by trained prenatal care providers (facilitators), the maternal module includes discussion of common OH problems during pregnancy, importance of OH, importance and safety of OH care during pregnancy, hands-on skills-building activities of learning and practicing proper tooth brushing and self-assessment of gum health, and presentation of illustrated flossing and OH promotion guides. The infant module includes discussion of infant oral hygiene, avoiding saliva sharing, proper nutrition, and importance of a dental visit by the first birthday. Activities in both modules utilize separate tool kits including tooth brushes, fluoride toothpaste, and other supplies.
Eligibility Criteria
You may qualify if:
- Women:
- speak, read, or write in English or Spanish
- enrolled in CP prenatal group care identified as study group
- free of any condition that requires them to take antibiotic or antibacterial medication prior to dental procedures
- provide informed consent
- Babies:
- healthy with no acute or chronic medical conditions, especially those conditions that may have resulted in hospitalizations and subsequent exposure to pathologic microorganisms
- free of any condition requiring antibiotic treatment currently or within the past three months.
- mothers provide informed consent for their children at baseline
You may not qualify if:
- \- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Berens, DDS, MPH
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2019
First Posted
June 28, 2019
Study Start
August 1, 2020
Primary Completion
July 1, 2022
Study Completion
July 31, 2022
Last Updated
January 23, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share